Biblio
Found 11 results
Filters: Author is Chen, Shuhua  [Clear All Filters]
.  
2013.  Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.. PLoS One. 8(11):e79977.
.  
2013.  Early intervention with an estrogen receptor β-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer's disease.. J Alzheimers Dis. 37(2):403-19.
.  
2013.  Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's.. PLoS One. 8(3):e59825.
.  
2013.  Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments.. Brain Res. 1514:128-41.
.  
2012.  Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.. Neurobiol Aging. 33(8):1507-21.
.  
2011.  17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention.. Neurobiol Aging. 32(11):1949-63.
.  
2011.  2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.. PLoS One. 6(7):e21788.
.  
2011.  Estrogen protection against mitochondrial toxin-induced cell death in hippocampal neurons: antagonism by progesterone.. Brain Res. 1379:2-10.
.  
2011.  Membrane estrogen receptors mediate calcium signaling and MAP kinase activation in individual hippocampal neurons.. Brain Res. 1379:34-43.
.  
2011.  Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.. Front Endocrinol (Lausanne). 2:117.
.  
2008.  Regenerative potential of allopregnanolone.. Brain Res Rev. 57(2):398-409.
